Summary: Tirzepatide (Zepbound), a GLP-1 receptor agonist, has been FDA-approved for obstructive sleep apnea (OSA) in people with obesity, raising questions about whether it could help some patients reduce or eliminate the need for CPAP. While weight loss from the drug may improve airway function in weight-related OSA, experts caution that CPAP should not be…
Summary: ResMed reported 10% revenue growth for the quarter ending Dec 31, 2024, reaching $1.3 billion, driven by strong demand for sleep devices, masks, and residential care software. CEO Mick Farrell highlighted “once-in-a-generation” opportunities presented by the rise of sleep-tracking wearables and GLP-1 therapies, which he believes will increase patient awareness and drive greater adoption…
Summary: Kadimastem shareholders have approved the company’s merger with NLS Pharmaceutics, moving the two firms closer to forming a combined Nasdaq-traded company. NLS plans to hold its own shareholder vote in the coming weeks to finalize the merger. Executives from both companies highlighted the potential value creation and opportunities for growth and innovation resulting from…
Summary: Sunset Healthcare Solutions has launched Brighter Pediatrics, a new product line designed to enhance pediatric respiratory therapy for home care providers and families. The line includes pediatric CPAP/NIV masks, ventilator circuits, and closed ventilation suction systems, along with the Microflow Microdial Flowmeter, which allows for precise oxygen adjustments for infants. Sunset Healthcare emphasizes its…
This article is for young men who aspire to preach but doubt their own abilities. I have in mind men who have discovered that good preaching has changed their lives and fed their souls. Miraculously, you — one who was born in sin — have come to love the word of God, and the gospel…